First Quadrant’s Cantel Medical Corporation CMD Stock Holding History

First Quadrant’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-8,090	Closed	-$745K	–	897
2018 Q3	$745K	Sell	8,090 -63,861	-89%	-$6.08M	0.02%	430
2018 Q2	$7.08M	Buy	71,951 +69,052	+2,382%	+$7.72M	0.13%	197
2018 Q1	$323K	Hold	2,899	–	–	0.01%	557
2017 Q4	$298K	Hold	2,899	–	–	0.01%	653
2017 Q3	$273K	Sell	2,899 -91	-3%	-$7.18K	0.01%	656
2017 Q2	$233K	Sell	2,990 -5,110	-63%	-$384K	﹤0.01%	660
2017 Q1	$649K	Hold	8,100	–	–	0.01%	507
2016 Q4	$638K	Hold	8,100	–	–	0.01%	507
2016 Q3	$632K	Hold	8,100	–	–	0.01%	512
2016 Q2	$557K	Hold	8,100	–	–	0.01%	477
2016 Q1	$578K	Sell	8,100 -10,500	-56%	-$659K	0.01%	477
2015 Q4	$1.16M	Buy	+18,600	New	+$1.13M	0.03%	367
2013 Q4	–	Sell	-2,250	Closed	-$72K	–	828
2013 Q3	$72K	Hold	2,250	–	–	﹤0.01%	640
2013 Q2	$51K	Buy	+2,250	New	+$48.7K	﹤0.01%	673

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

First Quadrant's CMD Position: Q4 2018 in Review

First Quadrant sold out of Cantel Medical Corporation (CMD) in Q4 2018, closing a stake of 8,090 shares — an estimated $745K sold.

First Quadrant first reported a position in CMD in Q2 2013 and held it in 14 quarters. The position peaked at $7.08M in Q2 2018. 253 funds tracked by Wall St. Rank hold CMD as of Q4 2018.

First Quadrant reported no remaining Cantel Medical Corporation position as of Q4 2018 after selling out during the quarter.
First Quadrant sold 8,090 Cantel Medical Corporation shares in Q4 2018, an estimated $745K.
First Quadrant first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 14 quarters.
First Quadrant's Cantel Medical Corporation position peaked at $7.08M in Q2 2018.
253 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2018.

Based on First Quadrant's 13F filing for Q4 2018, filed 24 Jan 2019.